Briefing
TiMBER: tumor-informed ctDNA and recurrence in muscle-invasive bladder cancer
Observational study of the Labcorp Plasma Detect assay in patients planned for curative-intent treatment of muscle-invasive urothelial carcinoma, with concordance between recurrence and ctDNA as the primary objective.
- Design: Not applicable · Recruiting